Generic: Enoxaparin

Trade Name: Lovenox

Anticoagulant
Low Molecular Weight Heparin

Anticoagulant that is used to treat blood clots and/or

prevent the formation blood clots that already exists
such as deep vein thrombosis (DVT) which can lead to
blood clots in the lungs (pulmonary embolism)
Lovenox is a low molecular weight (LMWH) form of
Heparin
Administration: IV or Subcutaneous
Major Interactions: Hypersensitivity (heparin Pork),
heparin-induced thrombocytopenia, leukemia with
bleeding
Although Lovenox's onset of action is unknown, its peak
time is 3-5 hours with a duration is 12 hours.
Major Side Effects: bleeding, anemia,
thrombocytopenia, and hemorrhaging from any site
Nursing Implication: obtain a baseline and
periodically for renal failure and monitor for bleeding
gums, bruising, bloody stools, presence of blood in
urine (hematuria). Check for injection site reactions
such as inflammation or redness. Notify physician if any
blood is present.
Testing: BUN (7-20 mg/dL) Creatinine level 0.5-1.5
mg/dL for men, 0.6-1.2 mg/dL for women, and
Complete blood count (CBC)
Patient Education: Report any signs of bleeding:
gums, under skin, urine, stools; do not rub injection
site, easy bruising, dizziness, rash, or breathing
changes.
Antidote for Enoxaparin/Lovenox is protamine sulfate